Wealth

LUND, Sweden, March 1, 2021 /PRNewswire/ — Hansa Biopharma, the pioneer in immunomodulatory enzyme technology for rare IgG mediated diseases, today announces the appointment of Magnus Korsgren, M.D., Ph.D. as Vice President and Head of Research and Development. Dr Korsgren will lead the efforts to advance Hansa Biopharma’s pipeline of drug candidates for rare immunologic … Read more

Aegon announced today that it has successfully completed the divestment of Stonebridge, a UK-based provider of accident insurance products to Global Premium Holdings group, part of Embignell group. As announced on October 9, 2020, the divestment will further simplify Aegon’s business profile. This is in line with Aegon’s strategy to actively manage its portfolio of … Read more

NEW BRUNSWICK, N.J., Feb. 27, 2021 /PRNewswire/ — Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical Companies of Johnson & Johnson, to prevent COVID-19 in individuals 18 years of age and older. … Read more

BRENTWOOD, Tenn., Feb. 27, 2021 /PRNewswire/ — Earlier today, a fire occurred at the Penex unit of our refinery in El Dorado, Arkansas. Our on-site emergency response team, with the assistance of the El Dorado Fire Department, extinguished the fire. We immediately began to monitor the air quality within the refinery and the community and have … Read more

LOS ANGELES, Feb. 27, 2021 /PRNewswire/ —  Goli Nutrition, creators of the world’s first Apple Cider Vinegar gummy and the world’s most powerful Ashwagandha (ASHWA) gummy, has expanded its existing partnership with Vitamin Angels for World Non-Governmental Organization (NGO) Day, donating a 5 year supply of essential vitamins to children in need for every purchase made … Read more

DUBAI, United Arab Emirates, Feb. 28, 2021 /PRNewswire/ — bfound is actively working to help SMEs adapt to post-Covid market dynamics and a large part of this activity is focused on helping businesses establish a sustainable capability to sell and market their businesses online. This includes working with new technology partners across a range of … Read more

NEW YORK, Feb. 27, 2021 /PRNewswire/ — Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Pandion Therapeutics, Inc. (“PAND” or the “Company”) (PAND) relating to its proposed … Read more

NEW YORK, Feb. 27, 2021 /PRNewswire/ — Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Protective Insurance Corp. (“PTVCA” or the “Company”) (PTVCA) relating to its proposed … Read more

House Speaker Nancy Pelosi is seen during a press conference on January 21, 2021. Justin Sullivan/Getty Images House Democrats approved President Joe Biden’s $1.9 trillion emergency spending package in a 219-212 vote early on Saturday morning, sending the legislation to the Senate as lawmakers rushed to head off the expiration of enhanced unemployment insurance in … Read more

NEW YORK, Feb. 27, 2021 /PRNewswire/ — Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Reinvent Technology Partners (“RTP” or the “Company”) (RTP) relating to its proposed … Read more

KURUME, Japan, Feb. 26, 2021 /PRNewswire/ — FCC Horiuchi Co., Ltd. based in Kurume City, Fukuoka Prefecture, western Japan, has conducted an experiment in inhibiting binding between ACE2 and virus spike protein using HORIUCHI L-FUCOIDAN, manufactured by the company, in collaboration with a graduate school of Kyushu University (Associate Professor Kuniyoshi Shimizu of Division of … Read more

PARIS and CAMBRIDGE, Mass., Feb. 26, 2021 (GLOBE NEWSWIRE) — Biophytis SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS), (“Biophytis” or the “Company”), a clinical-stage biotechnology company focused on the development of therapeutics that are aimed at slowing the degenerative processes associated with aging and improving functional outcomes for patients suffering from age-related diseases, including severe … Read more